My Journey to Jivi logo

Venkat Reddy

Venkat wasn’t formally diagnosed with hemophilia A until age 16 – but he didn’t let that stop him from building a healthy and fulfilling life.

Venkat smiling with his name Venkat Reddy and the My Journey to JIVI logo

Video title

YYMMDD Author/Uploaded by

Video title

YYMMDD Author/Uploaded by

Video title

YYMMDD Author/Uploaded by
Meet Venkat or other patients and caregivers at a live speaking event in your area. Hear their unique stories and connect one-on-one.
Venkat holding his daughter
Graphic with text saying Sometimes it was hard growing up – especially since I wasn’t diagnosed until I was 16 - but it makes me even more grateful to have access to such effective treatment now.
Venkat with his son on his shoulder with his wife and daughter standing in front of him
Venkat holding his son in a field
Venkat lying in the grass with his children
Graphic with text saying With Jivi, I feel I get effective bleed control, more time between infusions, and factor levels that meet my needs. Talking to my doctor helped me find the right product for me.
Graphic with text saying We have a really great community, and I am proud to be a part of it.
Venkat sitting in the park on grass

Hear more from patients and caregivers by attending a My Journey to Jivi event.

Meet other Jivi speakers

Patient Stories: Brandon Schrom

Brandon Schrom

Adventurer. Athlete. Scientist.

Patient Stories: Juan Pablo

Juan Pablo Lopez Padilla

Brother. Immigrant. Advocate.

A male patient, Ryan

Ryan Moulton

Father. Husband. Athlete.

A male patient, Zach

Zach Castillo

Lifelong Texan. Camp Counselor. Leader.

INDICATIONS

Jivi is an injectable medicine used to replace clotting factor (Factor VIII or antihemophilic factor) that is missing in people with hemophilia A.

Jivi is used to treat and control bleeding in previously treated adults and adolescents (12 years of age and older) with hemophilia A. Your healthcare provider may also give you Jivi when you have surgery. Jivi can reduce the number of bleeding episodes in adults and adolescents with hemophilia A when used regularly (prophylaxis).

Jivi is not for use in children below 12 years of age or in previously untreated patients.

Jivi is not used to treat von Willebrand disease.

IMPORTANT SAFETY INFORMATION

You should not use Jivi if you are allergic to rodents (like mice and hamsters) or to any ingredients in Jivi.

Tell your healthcare provider about all of your medical conditions that you have or had.

Tell your healthcare provider if you have been told that you have inhibitors to Factor VIII.

Allergic reactions may occur with Jivi. Call your healthcare provider right away and stop treatment if you get tightness of the chest or throat, dizziness, decrease in blood pressure, or nausea.

Allergic reactions to polyethylene glycol (PEG), a component of Jivi, are possible.

Your body can also make antibodies, called “inhibitors,” against Jivi, which may stop Jivi from working properly. Consult your healthcare provider to make sure you are carefully monitored with blood tests for the development of inhibitors to Factor VIII.

If your bleeding is not being controlled with your usual dose of Jivi, consult your doctor immediately. You may have developed Factor VIII inhibitors or antibodies to PEG and your doctor may carry out tests to confirm this.

The common side effects of Jivi are headache, cough, nausea, and fever.

These are not all the possible side effects with Jivi. Tell your healthcare provider about any side effect that bothers you or that does not go away.

For additional important risk and use information, please see the full Prescribing Information.

References: 1. Jivi® Prescribing Information. Whippany, NJ: Bayer LLC; 2018. 2. Data on file. Tx Review 0918. Bayer; 2018.